Inventor
NANDI INDRANIL
US21 patents
⚠️ This page may combine multiple inventors who share the name “NANDI INDRANIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JUBILANT DRAXIMAGE INC
7 patentsUS12226607B2Feb 18, 2025
Radiopharmaceutical delivery system and use thereof for patient infusion
JUBILANT DRAXIMAGE INC0 citations54
US12102789B1Oct 1, 2024
Radiopharmaceutical delivery system and use thereof for patient infusion
JUBILANT DRAXIMAGE INC0 citations54
US12390579B2Aug 19, 2025
Radiopharmaceutical delivery system for patient infusion
JUBILANT DRAXIMAGE INC0 citations52
US12417858B2Sep 16, 2025
Device to facilitate safe transport of medical radioisotope systems
JUBILANT DRAXIMAGE INC0 citations50
US12268547B2Apr 8, 2025
Imaging method for diagnosing cardiovascular disease
JUBILANT DRAXIMAGE INC0 citations40
US12588884B2Mar 31, 2026
Closed-loop elution system to evaluate patients with suspected or existing peripheral arterial disease
JUBILANT DRAXIMAGE INC0 citations36
US12539339B2Feb 3, 2026
Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof
JUBILANT DRAXIMAGE INC0 citations34
JUBILANT GENERICS LTD
6 patentsUS11020349B1Jun 1, 2021
Transmucosal dosage forms of remdesivir
JUBILANT GENERICS LTD5 citations70
US11318145B2May 3, 2022
Eslicarbazepine suspension
JUBILANT GENERICS LTD0 citations60
US10889549B2Jan 12, 2021
Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof
JUBILANT GENERICS LTD0 citations56
US11642351B2May 9, 2023
Eslicarbazepine suspension
JUBILANT GENERICS LTD0 citations49
US11331324B2May 17, 2022
Modified release suspension of eslicarbazepine
JUBILANT GENERICS LTD0 citations49
US11327065B1May 10, 2022
Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof
JUBILANT GENERICS LTD0 citations35
JUBILANT PHARMA HOLDINGS INC
3 patentsUS11583521B2Feb 21, 2023
Long-acting injection dosage form of beta 3 adrenoreceptor agonists
JUBILANT PHARMA HOLDINGS INC1 citations56
US11311518B1Apr 26, 2022
Parenteral dosage form of β3 adrenoreceptor agonists
JUBILANT PHARMA HOLDINGS INC1 citations51
US12514525B2Jan 6, 2026
Radiopharmaceutical dispensing systems
JUBILANT PHARMA HOLDINGS INC0 citations48